United States· US:10702-065_0f296f50-a802-d586-e063-6394a90a4888
Dextroamphetamine Sulfate
A dexamfetamine product containing dextroamphetamine sulfate, registered in United States by KVK-Tech, Inc.. The same ATC class is registered in 14 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Dexamfetamine is registered in 14 of 19 countries.
Countries holding a registration under ATC N06BA02 (dexamfetamine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Dexamfetamine · ATC N06BA02
14 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dexamfetamine costs, country by country.
Normalised to the WHO defined daily dose (15 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dexamfetamine · price per daily dose (15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$4.49
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DEXTROAMPHETAMINE SULFATE
- Manufacturer
- KVK-Tech, Inc.
- Country
- United States (US)
- ATC code
- N06BA02
- ATC class
- Dexamfetamine
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc111070206501100 TABLET in 1 BOTTLE (10702-065-01)
- ndc11107020650330 TABLET in 1 BOTTLE (10702-065-03)
- ndc11107020650660 TABLET in 1 BOTTLE (10702-065-06)
- ndc1110702-065-01
- ndc1110702-065-03
- ndc1110702-065-06
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
89 interactions on record for dexamfetamine.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dexamfetamine · interactions on record
89 records
- 16 severe
- 73 moderate
Most severe, free to view
- FenfluramineA08AA02severe
- DexfenfluramineA08AA04severe
- SibutramineA08AA10severe
- ProcarbazineL01XB01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dexamfetamine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAmfexa 5mg tabletsMedice UK Ltd
- NetherlandsAdhesa 5 mg tablettenACE Pharmaceuticals B.V.
- SwedenAdhesa 5 mg TablettAdvanz Pharma Limited
- FinlandAdhesaACE Pharmaceuticals BV
- NorwayAttentinMedice Arzneimittel Pütter GmbH & Co KG
- CanadaDEXEDRINEENDO OPERATIONS LTD.
- IcelandAttentinMedice Arzneimittel Pütter GmbH & Co. KG*
- PolandTentinMedice Arzneimittel Puetter GmbH & Co. KG
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Philla
- Belgium · Adhesa, Attentin
- Germany · Attentin, Dexamfetamin Orifarm
- Denmark · Adhesa, Attentin
- Estonia · Tentin
- Spain · Tentin
- Finland · Adhesa 5 Mg Tabletti, Attadex
- France · Tentin
- United Kingdom (Northern Ireland) · Amfexa, Dexamfetamine Sulfate
- Iceland · Attentin, Dexamfetamine Taw Pharma (Ireland)
- Italy · Amfexa
- Luxembourg · Attentin
- Malta · Dexamfetamine Sulfate
- Netherlands · Adhesa, Attenfarm
- Norway · Attentin, Deksamfetamin Waymade B.V.
- Poland · Tentin
- Portugal · Tentin
- Sweden · Attentin, Dexamfetamin Sea Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/549cff5e-61d4-4fbf-a1d0-0122b37c0e39 GET /v1/drugs/549cff5e-61d4-4fbf-a1d0-0122b37c0e39?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "5",
"substance": "DEXTROAMPHETAMINE SULFATE",
"productndc": "10702-065",
"dosage_form": "TABLET",
"dea_schedule": "CII",
"strength_unit": "mg/1",
"application_number": "ANDA203548",
"marketing_category": "ANDA"
}See everything about dexamfetamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.